Abstract Details

Title Propensity Score Matched Comparative Effectiveness Analysis of Dimethyl Fumarate Relative to Interferon, Glatiramer Acetate, or Teriflunomide Treated RRMS Outpatients in the German NeuroTransData Registry

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 351

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Arnfin Bergmann PRESENTER	Dr. Bergmann has nothing to disclose.
Stefan Braune (Gemeinschaftspraxis)	Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
	No disclosure on file
	No disclosure on file
John Vest	John Vest has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. John Vest has received stock or an ownership interest from Alnylam Pharmaceuticals. John Vest has received intellectual property interests from a discovery or technology relating to health care.
Robert Hyde, PhD (Biogen)	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
	No disclosure on file